Theresa Werner, MD

Financial relationships

  • Attribution:
    Self
    Type of financial relationship:
    Other
    Ineligible company:
    Mersana Therapeutics
    Topic:
    Advisor for clincial trial
    Date added:
    09/29/2022
    Date updated:
    09/29/2022
    Relationship end date:
    05/01/2022
Return to 2022 Precision Oncology Summit: Personalizing Treatment to Improve Patient Outcomes